PUBLICATION
            Generating X: formation of the optic chiasm
- Authors
- Rasband, K., Hardy, M., and Chien, C.-B.
- ID
- ZDB-PUB-031027-1
- Date
- 2003
- Source
- Neuron 39(6): 885-888 (Review)
- Registered Authors
- Chien, Chi-Bin, Rasband, Kendall
- Keywords
- none
- MeSH Terms
- 
    
        
        
            
                - Optic Chiasm/growth & development*
- Optic Chiasm/metabolism*
- Growth Substances/biosynthesis
- Growth Substances/genetics
- Humans
- Gene Expression Regulation, Developmental/physiology
- Animals
 
- PubMed
- 12971890 Full text @ Neuron
            Citation
        
        
            Rasband, K., Hardy, M., and Chien, C.-B. (2003) Generating X: formation of the optic chiasm. Neuron. 39(6):885-888.
        
    
                
                    
                        Abstract
                    
                    
                
                
            
        
        
    
        
            
            
 
    
    
        
    
    
    
        
                At the optic chiasm, axons from either eye meet and decide whether to cross contralaterally or turn back ipsilaterally. Here, the guidance ligand Slit and its receptor Robo control not whether axons cross (as in other midline decisions), but where the chiasm forms. Whether axons cross is instead controlled by the transcription factor Zic2 and the guidance receptor EphB1, as shown by two papers in the current issues of Neuron and Cell (Herrera et al. and Williams et al.). Surprisingly, this mechanism is conserved evolutionarily from frogs to mammals.
            
    
        
        
    
    
    
                
                    
                        Genes / Markers
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Expression
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Phenotype
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Mutations / Transgenics
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Human Disease / Model
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Sequence Targeting Reagents
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Fish
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Orthology
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Engineered Foreign Genes
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Mapping
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    